Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.


Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?


Please Try Again {{ error }}

Send my password

An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Buzz on the Bullboards: The Fast Movers & the Up-and-Comers

Stockhouse Editorial
1 Comment| March 31, 2022

{{labelSign}}  Favorites

On Buzz on the Bullboards, we normally provide the Stockhouse Community with a snapshot of recent Bullboard activity, often accompanied by an Investor Pulse Poll – providing you with information on current sentiment.

It has been generally difficult for energy companies to generate a lot of traction with investors recently. However, these companies have had a solid run in recent weeks and months and seem to be continuing that uptrend today.

Datametrex AI Ltd. (TSX-V:DM, Forum) is a technology-focused company with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy.

Datametrex is being recognized as an innovator in the cybersecurity industry thanks to its AI-based machine learning technology, Nexalogy.

Nexalogy has been used by organizations such as NATO, the Canadian Government and the US Armed Forces for nearly seven years with a consistent track record.

The company’s AI-based technology is currently being used by governments for data mining and social media conversation analysis which is critical in the fight to stop the spread of misinformation and propaganda around the world.

Datametrex along with its subsidiary, Nexalogy, has been featured by our own Stockhouse Publishing in the following article, The Software Stopping Misinformation on Russia’s War in Ukraine and continues to attract media attention as propaganda and misinformation are being used by corrupt global leaders to manipulate news and information on social media as the crisis intensifies in both Ukraine and Tigray, Ethiopia.

“Datametrex has developed tools and techniques that help shed light on misinformation and bring that to the attention of everyone involved so that the company can expose it and show the danger of fake news to the public,” said Marshall Gunter, CEO of Datametrex.

Aside from that incident at the Oscars that everyone is talking about, the invasion of Ukraine continues to weigh on the minds of investsors as much as the general public. A heavy-handed question was served in last week's Investor Pulse Poll ... met with the obvious heavy answer.

This week, cannabis is back in focus, specifically the niches within the sector where investors find exciting plays beyond cultivation and production. What are yours? Let us know by clicking the image below to cast your vote.

(Click to vote.)

One of the top names in the sector, Aleafia Health Inc. (TSX-V: ALEF, Forum) continues to increase its market share by focusing on its highest revenue-generating dried flower, pre-roll, and vape product categories.

Aleafia Health is a vertically integrated and federally licensed Canadian cannabis company, which owns three licensed cannabis production facilities.

Aleafia consumers continue to express strong interest in the Sunday Market House of Brands adult-use cannabis products in these categories.

In February, the company changed its business strategy towards being a branded cannabis products provider, with branded cannabis representing 80% of total net revenue in 2021 compared to 33% in 2020.

The company's chief executive, Tricia Symmes, commented,

“Now we continue to deliver on that strategy, with record growth in market share in February and unique product introductions that demonstrate the success of our Sunday Market House of Brands, setting the stage for future success in the highest volume cannabis categories.”

In February Aleafia Health achieved a record 2.06% adult-use market share in four major markets, advancing from 1.54% in November 2021.

The company recently shipped its first flower SKUs to BC, including 14-gram bags of Divvy Sour Kush and Flo, and 3.5-gram bags of Divvy Black Widow CBD.

“Divvy, the company’s well-established everyday brand, is focused on an exceptional value proposition, with a full suite of dried flower, pre-rolls, vapes and cannabis derivative products benefitting from supply agreements with Ontario, Alberta, Saskatchewan, British Columbia,” she said.

Aleafia received a $1 million purchase order from Ontario, covering a wide range of products. Aleafia Health has also secured purchase orders from Australia and Europe that exceed 2021 second-half sales to international markets.

Therma Bright Inc. (TSX-V:THRM, Forum) is the developer of the smart-enabled AcuVid COVID-19 Rapid Antigen Saliva Test.

The company has submitted its AcuVid COVID-19 Rapid Antigen Saliva Test for US FDA Emergency Use Authorization (EUA) approval.

“I am pleased to announce the submission of our AcuVid COVID-19 Rapid Antigen Saliva Test for US Food & Drug Administration’s Emergency Use Authorization,” shared Rob Fia, CEO of Therma Bright.

“Our application includes data from our US. clinical performance study, Brazilian clinical study, all required cross-reactivity tests, additional FDA requested cross-reactivity tests for mouth-borne viruses and bacteria, and numerous tests around World Health Organization’s "Variants of Concern", such as Delta and Omicron,” he added.

Since July 2021, its Executive and Development teams have worked with FDA officials, doctors and scientists on its AcuVid EUA application requirements.

The timing of this authorization process is unknown. Therefore, the company will only notify the market upon receipt of the FDA’s decision.

“The company has begun investigating another saliva-based testing technology incorporating a robust platform for detecting other respiratory infectious diseases affecting the lungs and a novel saliva-based platform for Neuro-Vascular disorders,” concluded Fia.

Therma Bright is not making any express or implied claims that its test product has the ability to eliminate or cure COVID-19 or the SARS-CoV-2 virus.

This test is a progressive medical diagnostic, and device technology company focused on providing consumers and medical professionals with quality, innovative solutions that address some of today’s most important medical and healthcare challenges.

Next week on Buzz, we will be back to our weekly reporting of Bullboard leaders. Stockhouse readers can also look forward to the results from our latest Investor Pulse Poll (on the homepage):

For previous editions of Buzz on the Bullboards: click here.

FULL DISCLOSURE: Datametrex AI Ltd. is a client of Stockhouse Publishing.

{{labelSign}}  Favorites